Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-03-06
DOI
10.1038/srep43864
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
- (2016) H. Hirata et al. CANCER RESEARCH
- Down Expression of FBP1 Is a Negative Prognostic Factor for Non–Small-Cell Lung Cancer
- (2015) Huaying Sheng et al. CANCER INVESTIGATION
- Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma
- (2015) James S Wilmott et al. MODERN PATHOLOGY
- Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells
- (2015) Juan Zhang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Class I HDACs Are Mediators of Smoke Carcinogen-Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung Cancer
- (2014) S. A. Brodie et al. Cancer Prevention Research
- Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
- (2014) Jinwon Seo et al. Journal of Breast Cancer
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Fructose-1,6-bisphosphatase opposes renal carcinoma progression
- (2014) Bo Li et al. NATURE
- Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
- (2013) Berit Maria Müller et al. BMC CANCER
- Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
- (2013) Chenfang Dong et al. CANCER CELL
- BRCA1 is a negative modulator of the PRC2 complex
- (2013) Lan Wang et al. EMBO JOURNAL
- HDAC Up-Regulation in Early Colon Field Carcinogenesis Is Involved in Cell Tumorigenicity through Regulation of Chromatin Structure
- (2013) Yolanda Stypula-Cyrus et al. PLoS One
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
- (2011) Mingquan Chen et al. PLoS One
- Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC
- (2011) Karl Quint et al. VIRCHOWS ARCHIV
- Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer
- (2010) Kathrin Mutze et al. ANNALS OF SURGICAL ONCOLOGY
- High Efficacy of Panobinostat Towards Human Gastrointestinal Stromal Tumors in a Xenograft Mouse Model
- (2009) G. Floris et al. CLINICAL CANCER RESEARCH
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
- (2009) M. C. Crisanti et al. MOLECULAR CANCER THERAPEUTICS
- Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
- (2009) X Liu et al. ONCOGENE
- Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor
- (2008) A. S. Beltran et al. MOLECULAR CANCER THERAPEUTICS
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now